论文部分内容阅读
最近有许多报告关于治疗早期和晚期帕金森病 (ＰＤ)新药的作用 ,如多巴胺激动剂和儿茶酚胺邻甲基转移酶抑制剂 (ＣＯＭＴＩ) ;另有老药如金刚烷胺和阿扑吗啡新作用的报道。多巴胺激动剂单药治疗早期ＰＤ 左旋多巴 (ＬＤ)仍然是早期ＰＤ治疗有效和耐受性的金标准。目前尚未证实
A number of recent reports have dealt with therapies for new and late-stage Parkinson’s disease (PD) drugs such as dopamine agonists and catecholamine ortho-methyltransferase inhibitors (COMTI); newer drugs such as amantadine and apomorphine Report. Monotherapy with dopamine agonists Early PD L-dopa (LD) remains the gold standard for efficacy and tolerability of early PD. It has not been confirmed yet